Center for Translational Medicine, Shanghai Key Laboratory of Diabetes Mellitus and Shanghai Key Laboratory of Sleep Disordered Breathing, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Commun Biol. 2024 May 27;7(1):641. doi: 10.1038/s42003-024-06321-3.
Bile acids (BAs) play important pathophysiological roles in both humans and mammalian animals. Laboratory rats and mice are widely used animal models for assessing pharmacological effects and their underlying molecular mechanisms. However, substantial physiological differences exist in BA composition between humans and murine rodents. Here, we comprehensively compare BA profiles, including primary and secondary BAs, along with their amino acid conjugates, and sulfated metabolites in serum, urine, and feces between humans and two murine rodents. We further analyze the capabilities in gut microbial transform BAs among three species and compare sex-dependent variations within each species. As a result, BAs undergo amidation predominately with glycine in humans and taurine in mice but are primarily unamidated in rats. BA sulfation is a unique characteristic in humans, whereas rats and mice primarily perform multiple hydroxylations during BA synthesis and metabolism. For gut microbial transformed BA capabilities, humans are comparable to those of rats, stronger than those of mice in deconjugation and 7α-dehydroxylation, while humans are weak than those of rats or mice in oxidation and epimerization. Such differences enhance our understanding of the divergent experimental outcomes observed in humans and murine rodents, necessitating caution when translating findings from these rodent species to humans.
胆汁酸(BAs)在人类和哺乳动物中都发挥着重要的病理生理学作用。实验室大鼠和小鼠是广泛用于评估药理学效应及其潜在分子机制的动物模型。然而,人类和鼠类之间的 BA 组成存在显著的生理差异。在这里,我们全面比较了人类和两种鼠类的血清、尿液和粪便中的初级和次级 BA 及其与氨基酸的结合物,以及磺酸化代谢物的 BA 谱。我们进一步分析了三种物种中肠道微生物转化 BA 的能力,并比较了每个物种中性别相关的变化。结果表明,BA 在人类中主要与甘氨酸发生酰胺化,而在小鼠中则主要与牛磺酸发生酰胺化,但在大鼠中则主要是非酰胺化。BA 磺酸化是人类的一个独特特征,而大鼠和小鼠则主要在 BA 合成和代谢过程中进行多次羟化。对于肠道微生物转化的 BA 能力,人类与大鼠相当,在去结合和 7α-脱羟化方面强于小鼠,而在氧化和差向异构化方面弱于大鼠或小鼠。这些差异增强了我们对人类和鼠类实验结果差异的理解,当将这些啮齿动物物种的研究结果转化到人类时需要谨慎。